FBXL18通过破坏DUSP16的稳定性来促进子宫内膜癌的进展,从而激活JNK信号通路
Jie Pi1, Yong Wang1, Yuzi Zhao1
1Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Cancer cell international
|May 17, 2025
概括
富含F盒和白的重复蛋白18 (FBXL18) 通过降解DUSP16和激活JNK/c-JUN信号,促进子宫内膜癌 (EC) 的进展. 这一发现为EC患者提供了潜在的治疗目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 子宫内膜癌 (EC) 具有有限的治疗选择和不良预后.
- 在EC中,F-box和富含白的重复蛋白18 (FBXL18) 的作用在很大程度上仍未被探索.
研究的目的:
- 研究FBXL18在子宫内膜癌中的表达,功能和机制.
- 评估FBXL18作为潜在的预后标志物和EC中的治疗标.
主要方法:
- 在EC组织和细胞系中通过数据挖掘和实验进行FBXL18表达分析.
- 在体外测试 (CCK-8,殖民地形成,伤口愈合,Transwell) 来评估FBXL18的功能影响.
- 生物信息分析,西部污染,qRT-PCR,Co-IP和无处不在测试以确定下游目标和途径.
主要成果:
- FBXL18在EC表达很高,与患者的不良结果相关.
- FBXL18的淘汰抑制了EC细胞的增殖,迁移和入侵;过度表达增强了这些.
- FBXL18针对DUSP16进行无处不在和降解,激活JNK/c-JUN信号通路.
结论:
- FBXL18在EC上升调节,并促进瘤的进展.
- FBXL18通过降解DUSP16和激活JNK/c-JUN信号来促进EC进展.
- FBXL18显示出预后价值,并代表了EC的潜在治疗标.
相关概念视频
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Canonical Wnt Signaling Pathway
8.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K


